Dr. Wacker proposes a novel approach to drug discovery that focuses in on a specific serotonin receptor known as 5-HT7R (which doesn't carry the same risks as activating the dopamine system as many drugs do), carefully mapping that receptor's structure at a molecular scale, and seeking out compounds that will bind to that receptor in a specific way.
Dr. Wacker wuxuu soo jeedinayaa hab cusub oo sheeko ku saabsan daahfurka daroogada kaas oo diiradda saaraya qaabilaad gaar ah oo loo yaqaan 'Serotonin receptor' oo loo yaqaan 5-HT7R (oo aan lahayn halista la mid ah dhaqdhaqaaqa nidaamka dopamine-ka sida dawooyin badani u qabtaan), si taxaddar leh khariidadda qaab-dhismeedka qaab-dhismeedka cabirka molikaligga, iyo raadinta xeryo ku xirmi doona soo-dhoweyntaas qaab gaar ah.